scholarly journals 125TiP SGNTUC-019: Phase II basket study of tucatinib and trastuzumab in previously treated solid tumours with HER2 alterations: HER2-mutated breast cancer cohort

2021 ◽  
Vol 32 ◽  
pp. S74-S75
Author(s):  
A. Okines ◽  
V. Kang ◽  
L.N. Walker ◽  
P.R. Pohlmann
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Solid Tumours ◽  
Breast Cancer Cohort ◽  
Previously Treated

scholarly journals Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

2019 ◽  
Vol 30 (3) ◽  
pp. 397-404 ◽  
Author(s):  
S. Adams ◽  
P. Schmid ◽  
H.S. Rugo ◽  
E.P. Winer ◽  
D. Loirat ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Breast Cancer Cohort ◽  
Previously Treated

A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines

Oncology ◽  
2008 ◽  
Vol 75 (3-4) ◽  
pp. 175-181 ◽  
Author(s):  
Patrizia Vici ◽  
Luigi Di Lauro ◽  
Domenico Sergi ◽  
Paolo Foggi ◽  
Giuditta Viola ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Previously Treated

A Phase II Trial of Iproplatin (CHIP) in Previously Treated Advanced Breast Cancer

1989 ◽  
Vol 12 (2) ◽  
pp. 129-131 ◽  
Author(s):  
Dennis J. Meisner ◽  
Sandra Ginsberg ◽  
Allan Ditch ◽  
Arthur Louie ◽  
Nancy Newman ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Previously Treated

Phase II Trial of Capecitabine and Weekly Paclitaxel in Patients with Metastatic Breast Cancer Previously Treated with Every-3-Week Taxane Therapy

2007 ◽  
Vol 7 (6) ◽  
pp. 465-470 ◽  
Author(s):  
Joanne L. Blum ◽  
E. Claire Dees ◽  
Svetislava J. Vukelja ◽  
Mammo Amare ◽  
David P. Gill ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Weekly Paclitaxel ◽  
Previously Treated

Phase II study of cabazitaxel as second-line treatment in patients with HER-2 negative metastatic breast cancer previously treated with taxanes.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 1089-1089
Author(s):  
Angelos Koutras ◽  
Flora Zagouri ◽  
Georgia-Angeliki Koliou ◽  
Georgios Lazaridis ◽  
Dimitrios Tryfonopoulos ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
Line Treatment ◽  
Second Line ◽  
Previously Treated ◽  
Her 2
Sign in / Sign up

Export Citation Format

Share Document